Arthur Gonsalves, MD
Vascular Surgery · Methuen, MANPI 1235216870
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,600 of the $13,742 with a category attached, or 99.0%. Abiomed accounts for 99.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $7,400 and has fallen 58.8% since, to $3,049 in 2024.
Across 8 payments — averaging $1717.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$14K
- W. L. Gore & Associates, Inc.$92
- Ossur Americas, Inc.$5
What the payments were for
- Speaking & faculty fees$13,60099%
- Travel & lodging$440%
- Food & beverage$981%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 6 | $13,644 |
| W. L. Gore & Associates, Inc. | 1 | $92 |
| Ossur Americas, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$13,600
How this compares
$13,742 in reported general payments places this provider in the 75th percentile of 142 vascular surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 83 | $114,342 |
| Atorvastatin Calcium | 150 | $2,015 |
| Rosuvastatin Calcium | 17 | $788 |
| Pentoxifylline | 23 | $738 |
| ClopidogrelClopidogrel Bisulfate | 28 | $493 |
| Tramadol Hcl | 14 | $184 |
| Atenolol | 21 | $160 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $142 |
| Triamcinolone Acetonide | 14 | $139 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $137 |
| Lorazepam | 60 | $95 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Methuen
- Katie SheanMethuen$6K
- Thomas OdonnellBoston$845K
- Scott JamesPlymouth$199K
- Anahita DuaBoston$186K
- Dejah JudelsonWorcester$92K
- Jonathan GertlerWeston$90K
- Andres SchanzerWorcester$84K
- Richard PinNorth Dartmouth$73K
- Marc SchermerhornBoston$71K
- Edwin GravereauxBoston$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.